Skip to main navigation Skip to search Skip to main content

Mucinous cancer of the appendix: Challenges in diagnosis and treatment

  • E. Andreopoulou
  • , H. Yee
  • , M. A. Warycha
  • , M. Macari
  • , R. Berman
  • , A. Lowy
  • , F. Muggia

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The authors report and discuss a case of a mucinous carcinoma of the appendix, a rare entity with a distinct natural history that poses diagnostic and therapeutic challenges. Mucinous peritoneal carcinomatosis is most commonly associated with primary tumors of the appendix and colon. Typically, spread remains confined to the abdominal cavity. Imaging assessment of these mucinous lesions is difficult, while tumor markers (CEA and CA19.9) may be surrogates for extent of disease. Treatment consists of surgical debulking, sometimes coupled with intraperitoneal drug delivery, but recurrence is universal. New treatment approaches are needed. Mucin genes are regulated in part by epidermal growth factor receptor signaling. Therefore, we initiated a phase II study of cetuximab for mucinous peritoneal carcinomatosis, that was part of this patient's treatment.

Original languageEnglish
Pages (from-to)451-454
Number of pages4
JournalJournal of Chemotherapy
Volume19
Issue number4
DOIs
StatePublished - Aug 2007
Externally publishedYes

Keywords

  • Cetuximab
  • Cytoreductive surgery
  • Mucinous adenocarcinoma

Fingerprint

Dive into the research topics of 'Mucinous cancer of the appendix: Challenges in diagnosis and treatment'. Together they form a unique fingerprint.

Cite this